RiverValley Behavioral Health Amethyst Center
-
Services:
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
- This facility administers/prescribes medication for alcohol use disorder
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- In-network prescribing entity
- Outcome follow-up after discharge
- Aftercare/continuing care
- Naloxone and overdose education
- Discharge Planning
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Assistance with obtaining social services
- Mentoring/peer support
- Self-help groups
- Housing services
- Employment counseling or training
- Commission on Accreditation of Rehabilitation Facilities (CARF)
- State Substance use treatment agency
- Interim services for clients
- Comprehensive mental health assessment
- Complete medical history/physical exam
- Screening for substance use
- Comprehensive substance use assessment
- Outreach to persons in the community
- Screening for tobacco use
- Professional interventionist/educational consultant
- Screening for mental disorders
- Adult women
- Pregnant/postpartum women
- Private non-profit organization
- Treatment for gambling disorder
- Smoking not permitted
- Vaping not permitted
- Accepts clients using MAT but prescribed elsewhere
- Buprenorphine maintenance
- Relapse prevention with naltrexone
- Integrated primary care services
- Suicide prevention services
- Case management service
- Domestic violence services, including family or partner
- Cognitive behavioral therapy
- Substance use disorder counseling
- Anger management
- 12-step facilitation
- Matrix Model
- Motivational interviewing
- Relapse prevention
- Trauma-related counseling
- Hospital inpatient treatment
- Short-term residential
- Hospital inpatient/24-hour hospital inpatient
- Residential/24-hour residential
- Medication for mental disorders
- Acamprosate (Campral®)
- Nicotine replacement
- Naltrexone (extended-release, injectable)
- Naltrexone (oral)
- Buprenorphine with naloxone
- Young Adults
- Adults
- Group counseling
- Health education services other than HIV/AIDS or hepatitis
- Smoking/vaping/tobacco cessation counseling
- HIV or AIDS education, counseling, or support
- Individual counseling
- Substance use disorder education
- Sign language services for the deaf and hard of hearing
- Cash or self-payment
- Private health insurance
- Medicaid
- Federal, or any government funding for substance use treatment programs
- Female
- TB screening
- STD testing
- Testing for Hepatitis C (HCV)
- HIV testing
- Drug or alcohol urine screening
- Metabolic syndrome monitoring
- Testing for Hepatitis B (HBV)
- In-network prescribing entity
- Other contracted prescribing entity
Type of Care
Type of Alcohol Use Disorder Treatment
External Opioid Medications Source
Transitional Services
Opioid Medications used in Treatment
Recovery Support Services
License/Certification/Accreditation
Assessment/Pre-treatment
Special Programs/Groups Offered
Facility Operation (e.g., Private, Public)
Other Services
Facility Smoking Policy
Facility Vaping Policy
Type of Opioid Treatment
Ancillary Services
Treatment Approaches
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Pharmacotherapies
Age Groups Accepted
Education and Counseling Services
Language Services
Payment/Insurance/Funding Accepted
Gender Accepted
Testing
External Source of Medications Used for Alcohol Use Disorder Treatment